The human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of a drug with the SMILES CCN1C(=O)[C@@H]2[C@@H](c3ccc(-c4ccc(OC)cc4)cc3)N3CCC[C@@]3(C(=O)OC)[C@@H]2C1=O.O=C(O)C(F)(F)F is 4.567\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1C(=O)[C@@H]2[C@@H](c3ccc(-c4ccc(OC)cc4)cc3)N3CCC[C@@]3(C(=O)OC)[C@@H]2C1=O.O=C(O)C(F)(F)F
CCN1C(=O)[C@@H]2[C@@H](c3ccc(-c4ccc(OC)cc4)cc3)N3CCC[C@@]3(C(=O)OC)[C@@H]2C1=O.O=C(O)C(F)(F)F
methyl (3aS,4S,8aS,8bR)-2-ethyl-4-[4-(4-methoxyphenyl)phenyl]-1,3-dioxo-3a,4,6,7,8,8b-hexahydropyrrolo[3,4-a]pyrrolizine-8a-carboxylate;2,2,2-trifluoroacetic acid